Cannabis-alcohol co-use rose after COVID, with treatment gaps
A Random Forest Analysis of Risk Factors and Trends in Substance Use Treatment Among Those Who Use Cannabis and Alcohol Together Before and After the COVID-19 Pandemic.
AI Summary
This national survey analysis examined people who used cannabis during their most recent alcohol use, comparing patterns before COVID-19 with 2023. Across the study period, 24,526 respondents (5%) reported combined use, and co-use increased significantly. Because combining alcohol and cannabis can contribute to injuries, social difficulties, and worsening health conditions, the findings highlight an important public-health concern for people who use both substances together.
Treatment use also rose, from 274 people (2.1%) before COVID-19 to 141 people (4.2%) in 2023, although the authors conclude that treatment rates remain in need of improvement. Random forest and regression analyses identified cannabis accessibility as a major factor in both periods, while stimulant-product use was associated with co-use before COVID-19 and psychotherapeutic medication misuse afterward. The authors suggest that lasting changes in mental health and substance use after the pandemic may be influencing these patterns.
π‘ Key Findings
π
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
U.S. survey finds distinct patterns of frequent alcohol, nicotine, andβ¦
Treatment records show a sharp rise in stimulant use in Oman, 2019β2024
An 18-month cohort found adverse outcomes were infrequent, but long-term risksβ¦
Explore More Research
Stay informed about the latest cannabis science.